ORXES
Live / Allowed — Notice of allowance issued (as of 27 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99221728
- Mark type
- Word mark
- Filed
- 06 Jun 2025
- Published for opposition
- 02 Dec 2025
- Attorney of record
- Susan A. Smith
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Medicinal preparations for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Pharmaceutical preparations for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Plant extracts, other than essential oils, for pharmaceutical purposes; Diagnostic preparations for medical purposes; Medicated shampoo; Biologics in the nature of pharmaceutical preparations for the treatment of pulmonary arterial hypertension, hypertension, and stroke; Biological preparations for the prevention and treatment of pulmonary arterial hypertension, hypertension, and stroke
Owner
- ORxes Therapeutics Co., Ltd., Shenyang, Liaoning, CN
- ORxes Therapeutics Co., Ltd., Shenyang, Liaoning, CN
Prosecution history
- 27 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Dec 2025 — PUBLISHED FOR OPPOSITION
- 26 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Oct 2025 — ASSIGNED TO EXAMINER
- 13 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 06 Jun 2025 — NEW APPLICATION ENTERED